CPHI

CHINA PHARMA HLDGS INC

CPHI·16941T401·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic

CPHI (CHINA PHARMA HLDGS INC) is held by 5 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($82,806), RENAISSANCE TECHNOLOGIES LLC ($9,931), JANE STREET GROUP, LLC ($9,167). Net institutional sentiment: Bullish.

5
Holders
$103,957
Total Value
80% (5)
Consensus
4 buying - 1 selling
13F: Insider & Congress: Updated regularly
CPHI

Smart Money Verdict

View all
Loading verdict
Held by 5 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for CPHI.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
125,445(+870.6%)$82,8060.0%+38.60%
24
Increased
15,045(+31.8%)$9,9310.0%-44.08%
15
New
13,886$9,1670.0%+36.23%
26
Increased
3,109(+699.2%)$2,0520.0%+1.16%
12
Unchanged
1$10.0%-50.87%
0
Exited
0(-100.0%)$6080.0%+20.00%
0
CPHICPHICHINA PHARMA HLDGS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used